Rhythm Pharmaceuticals (RYTM) Interest & Investment Income (2016 - 2026)
Rhythm Pharmaceuticals' (RYTM) quarterly Interest & Investment Income came in at $3.6 million in Q1 2026, down 2.34% year-on-year from $3.6 million in Q1 2025, and down 13.0% on a QoQ basis from $4.1 million in Q4 2025.
Rhythm Pharmaceuticals (RYTM) Interest & Investment Income (2016 - 2026) Analysis & Trends
Rhythm Pharmaceuticals (RYTM) has 11 years of Interest & Investment Income data on file, last reported at $3.6 million in Q1 2026.
- On a quarterly basis, Interest & Investment Income fell 2.34% year-over-year to $3.6 million in Q1 2026; TTM through Mar 2026 was $15.2 million, a 0.63% decrease from a year earlier, with the FY2025 full-year figure at $15.3 million, up 3.96% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $3.6 million, down from $4.1 million in the prior quarter.
- Over the last five years, Interest & Investment Income for RYTM reached as high as $4.3 million in Q3 2025 and fell as low as $160000.0 in Q1 2022.
- Historically, Interest & Investment Income has averaged $3.1 million across 5 years, with a median of $3.5 million in 2023.
- Across the five-year window, Interest & Investment Income soared 2169.4% in 2022 and decreased 20.87% in 2025, its largest moves.
- Year by year, Interest & Investment Income stood at $3.0 million in 2022, then increased by 25.58% to $3.8 million in 2023, then decreased by 7.96% to $3.5 million in 2024, then gained by 16.22% to $4.1 million in 2025, then dropped by 13.0% to $3.6 million in 2026.
- Per Business Quant data, the three most recent Interest & Investment Income figures were $3.6 million in Q1 2026, $4.1 million in Q4 2025, and $4.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | Rhythm Pharmaceuticals | 7.27 Bn | 6.93 Bn | 52.96 Mn | 3.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.55 Mn |
| Dec 31, 2025 | 4.09 Mn |
| Sep 30, 2025 | 4.33 Mn |
| Jun 30, 2025 | 3.24 Mn |
| Mar 31, 2025 | 3.64 Mn |
| Dec 31, 2024 | 3.52 Mn |
| Sep 30, 2024 | 4.05 Mn |
| Jun 30, 2024 | 4.10 Mn |
| Mar 31, 2024 | 3.05 Mn |
| Dec 31, 2023 | 3.82 Mn |
| Sep 30, 2023 | 3.47 Mn |
| Jun 30, 2023 | 3.22 Mn |
| Mar 31, 2023 | 3.44 Mn |
| Dec 31, 2022 | 3.04 Mn |
| Sep 30, 2022 | 920,000.00 |
| Jun 30, 2022 | 274,000.00 |
| Mar 31, 2022 | 160,000.00 |
| Dec 31, 2021 | 134,000.00 |
| Sep 30, 2021 | 138,000.00 |
| Jun 30, 2021 | 21,000.00 |